Literature DB >> 6414861

Defective oxidative metabolism of heart mitochondria from genetically diabetic mice.

T H Kuo, K H Moore, F Giacomelli, J Wiener.   

Abstract

Long chain saturated beta-hydroxy fatty acid content and oxidative metabolism were studied in hearts of diabetic mice (C57BL/KsJ db/db) with a progressive cardiomyopathy at intervals of 7, 10, 16, and 26 wk of age. Total beta-hydroxy fatty acid (BHFA) content increases progressively with age in diabetic hearts with a mean value of 143.5 nmol/g dry wt as compared with a mean of 59.6 nmol/g dry wt in control hearts. There was also a redistribution of BHFA in myocardium of diabetic mice when compared with controls, with a relative decrease in beta-hydroxymyristate and an increase of beta-hydroxypalmitate. Oxidative phosphorylation studies using isolated mitochondria from diabetic mice demonstrated depressed state 3 oxidation rates with both palmityl carnitine and pyruvate as substrates. While mitochondrial NADH-oxidase activity was not statistically different from that of controls, there was a significant decrease in mitochondrial total NAD + NADH content in diabetic hearts. In addition, treatment of myocardial tissue with lanthanum demonstrated an abnormal permeability of sarcolemmal, intercalated disc as well as mitochondrial membranes in myocytes of diabetic mice. The data indicate that deficiencies in total NAD + NADH content can account for the depressed state 3 oxidation of palmitylcarnitine and pyruvate in diabetic mice that in turn may explain the abnormal accumulation of BFHA. The latter could play a role in altering the permeability of cardiac cell membranes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6414861     DOI: 10.2337/diab.32.9.781

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

1.  Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome.

Authors:  Olesya Ilkun; Nicole Wilde; Joseph Tuinei; Karla M P Pires; Yi Zhu; Heiko Bugger; Jamie Soto; Benjamin Wayment; Curtis Olsen; Sheldon E Litwin; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2015-05-22       Impact factor: 5.000

Review 2.  Mechanisms of subcellular remodeling in heart failure due to diabetes.

Authors:  Naranjan S Dhalla; Nobuakira Takeda; Delfin Rodriguez-Leyva; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 3.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

4.  Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes.

Authors:  Brittany A Law; Xianghai Liao; Kelsey S Moore; Abigail Southard; Patrick Roddy; Ruiping Ji; Zdzislaw Szulc; Ala Bielawska; P Christian Schulze; L Ashley Cowart
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 5.  Diabetes and the risk of heart failure.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Heart Fail Clin       Date:  2011-10-13       Impact factor: 3.179

6.  Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Shelley Zieroth; Yan-Jun Xu
Journal:  Exp Clin Cardiol       Date:  2012-09

7.  Mitochondrial dysfunction and its impact on diabetic heart.

Authors:  Suresh Kumar Verma; Venkata Naga Srikanth Garikipati; Raj Kishore
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-09-01       Impact factor: 5.187

8.  Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart.

Authors:  Tara L Croston; Dharendra Thapa; Anthony A Holden; Kevin J Tveter; Sara E Lewis; Danielle L Shepherd; Cody E Nichols; Dustin M Long; I Mark Olfert; Rajaganapathi Jagannathan; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

9.  Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism.

Authors:  Caroline Ojaimi; Shintaro Kinugawa; Fabio A Recchia; Thomas H Hintze
Journal:  Cardiovasc Diabetol       Date:  2010-08-24       Impact factor: 9.951

Review 10.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.